2023-01-31 15:08:00

Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer rese

Logo Benzinga
By Business Wire

Study to investigate effectiveness of early-stage pancreatic cancer detection using patented exosome-isolation technology

Biological Dynamics, a company commercializing its exosome-isolation ExoVerita platform, announced a collaboration with the Perlmutter Cancer Center at NYU Langone Health to validate its application for the early detection of pancreatic ductal adenocarcinoma (PDAC).

The collaboration will test retrospective samples from over 200 patients starting this month. The ExoVerita platform is being investigated at NYU Langone Health, among other premier institutions, with a goal of advancing treatment options for high-risk PDAC patients.

"Pancreatic cancer is predicted to be the second leading cause of cancer-related deaths by 2030. Exploring new technologies that can detect cancers sooner in high-risk patients is critical to improving patient outcomes and the quality-of-life years following diagnosis," says principal investigator, Diane Simeone, MD, surgical oncologist and director, pancreatic cancer center at NYU Langone's Perlmutter Cancer Center. "I am very interested in collaborating with Biological Dynamics to advance research in developing an early detection blood-based test for pancreatic cancer."

Continue read on benzinga.com

Logo GlobeNewswire
HealthPress Release2023-01-30 21:05:00
SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc.(Nasdaq: XGN),a leading provider of autoimmune testing solutions, today announced its participation...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-31 07:00:00
Axion BioSystems today announces the addition of the Omni Pro 12 to the Omni live-cell imaging product family. The new platform, which features integrated...

Logo GlobeNewswire
SciencePress Release2023-01-31 12:00:00
Patient screening to initiate; topline data expected by mid-2023 BOCA RATON, Fla., Jan. 31, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI)...

Logo GlobeNewswire
SciencePress Release2023-01-31 11:50:00
CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical stage biopharmaceutical company that aims to create...

Logo PR Newswire
HealthPress Release2023-01-31 11:30:00
The UCI Health Chao Family Comprehensive Cancer Center joins Caris' extensive network of leading cancer institutions committed to utilizing clinical data to...

Logo EIN Presswire
HealthPress Release2023-01-31 10:14:53
Cancer Diagnostics Market Growth The global cancer diagnostics market is estimated to account for US$ 45,106.5 Mn in terms of value and is expected to reach...

Logo PR Newswire
HealthPress Release2023-01-31 15:05:00
WASHINGTON, Jan. 31, 2023 /PRNewswire/ -- U.S. Representatives Debbie Dingell, John James and Terri Sewell, along with Dr. Danielle Carnival, Coordinator of...

Logo PR Newswire
HealthPress Release2023-01-31 12:00:00
Eligible Oral Cancer Drug Donations are Now Being Accepted at All Cancer & Hematology Centers of Western Michigan Specialty Retail Pharmacy Locations...

Logo NewsFileCorp
Press Release2023-01-31 08:15:00
Vancouver, British Columbia--(Newsfile Corp. - January 31, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the "...

Logo The Business Journals
Technology2023-01-30 21:58:44
Check out this startup that's working on precision drug delivery

Logo GlobeNewswire
SciencePress Release2023-01-30 21:01:00
2022 Success Has Increased Confidence to Focus LNC Delivery Platform on the Future of Medicine - Delivering Genes Prioritization on Building External...

Logo PR Newswire
DUBLIN, Jan. 30, 2023 /PRNewswire/ -- Research and Markets The "In-Vitro Colorectal Cancer Screening Tests - Global Strategic Business Report" report has...

Logo PR Newswire
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XELA, GNS, AEMD, GMVD, and HSCS.

Logo Benzinga
Business / FinanceBy Pr Com2023-01-30 16:35:49
Newburgh, NY January 30, 2023 --( PR.com )-- New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, and...

Logo NewsFileCorp
Press Release2023-01-31 12:30:00
Toronto, Ontario--(Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (" PharmaDrug " or the " Company "), a specialty...

Logo GlobeNewswire
SciencePress Release2023-01-31 12:30:00
TORONTO and HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp.(Medicenna or the Company) (NASDAQ: MDNA TSX: MDNA), a clinical stage...

Logo PR Newswire
HealthPress Release2023-01-31 13:01:00
Presentation on Thursday, February 2nd, 2023 at 10:00 AM ET SAN DIEGO, Jan. 31, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company...

Logo PR Newswire
HealthPress Release2023-01-31 13:50:00
SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative therapies for the...

Logo PR Newswire
HealthPress Release2023-01-31 14:05:00
BRENTWOOD, Tenn., Jan. 31, 2023 /PRNewswire/ -- Horizon Oncology and Research Center announced a new agreement with Integra Connect, the manager of Anthem's...

Logo PR Newswire
HealthPress Release2023-01-31 13:05:00
Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit's AI...